0001144204-17-004104.txt : 20170126
0001144204-17-004104.hdr.sgml : 20170126
20170126180540
ACCESSION NUMBER: 0001144204-17-004104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170125
FILED AS OF DATE: 20170126
DATE AS OF CHANGE: 20170126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC
CENTRAL INDEX KEY: 0001037649
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 943123681
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 135 BEAVER ST
CITY: WATHAM
STATE: MA
ZIP: 02452
BUSINESS PHONE: 1-781-398-0700
MAIL ADDRESS:
STREET 1: 135 BEAVER ST
CITY: WATHAM
STATE: MA
ZIP: 02452
FORMER COMPANY:
FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC
DATE OF NAME CHANGE: 19971003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Carbeau Mark B
CENTRAL INDEX KEY: 0001339155
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32715
FILM NUMBER: 17551190
MAIL ADDRESS:
STREET 1: C/O KINETIC CONCEPTS, INC
STREET 2: 8023 VANTAGE DRIVE
CITY: SAN ANTONIO
STATE: TX
ZIP: 78230
4
1
v457640_form4.xml
FORM 4
X0306
4
2017-01-25
0
0001037649
INTERLEUKIN GENETICS INC
ILIU
0001339155
Carbeau Mark B
C/O INTERLEUKIN GENETICS, INC.
135 BEAVER STREET
WALTHAM
MA
02452
1
1
0
0
CEO
Stock Option (Right to Buy)
0.1237
2017-01-25
4
A
0
1278653
0
A
2027-01-25
Common Stock
1278653
1278653
D
The exercise price of the option is the closing price of the Issuer's common stock on the OTCQB on January 25, 2017, which was the grant date of the option.
The option vests as to 25% of the shares on January 25, 2018, and 1/36th of the shares on the first day of each month beginning on February 1, 2018.
/s/ Brian P. Keane, Attorney-in-Fact
2017-01-26